Newswire iconNewswireSep 12, 2026

CMS's Hemp CBD Program Has A Physician Problem - MMJ Appeal Pending

In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials. as CMS carries its cannabinoid initiative into the 10-year LEAD Medicare model

CMS's Hemp CBD Program Has A Physician Problem - MMJ Appeal Pending

Share this story

Send the public story page.

Useful takeaways from this story.

In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials.

as CMS carries its cannabinoid initiative into the 10-year LEAD Medicare model

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials. as CMS carries its cannabinoid initiative into the 10-year LEAD Medicare model

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app